Trump's tariffs are meant to promote investment in domestic manufacturing, but experts told Scripps News the reality of relocating supply chains is complicated and will not happen quickly.

Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.

Mortgage rates are seen as stable, staying below 7% for much of the year so far. But continued economic uncertainty is making ...

Morristown-based Sanofi will be the latest U.S. drugmaker to inject billions of dollars into domestic operations and American manufacturing.

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Sanofi joins a growing chorus of drugmakers boosting their U.S. operations in the face of President Trump's trade policies.

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

Russia's oil and gas revenue is seen falling by a third in May from a year earlier to 0.52 trillion roubles ($6.48 billion), ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Walmart’s chief financial officer warned that the ‘magnitude’ of Trump’s tariffs was more than any retailer and supplier ‘can ...

Canada's First Nations are increasingly buying stakes in Canadian energy projects as they seek economic benefits from ...

US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...